Q1 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$5M+8.0% YoY

Gross Profit

$3M58.9% margin

Operating Income

-$6M-105.1% margin

Net Income

-$6M-103.2% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

+5.0%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$50M

Total Liabilities

$18M

Stockholders' Equity

$33M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$5M	+8.0%
Gross Profit	$3M	$3M	-0.9%
Operating Income	-$6M	-$4M	-47.8%
Net Income	-$6M	-$4M	-41.7%

Revenue Segments

Biologics And Drug Delivery

$3M30%

Functional Neurosurgery Navigation and Therapy

$2M27%

Functional Neurosurgery Navigation and Therapy - Disposable Products

$2M21%

Biologics And Drug Delivery - Disposable Products

$594,0007%

Functional Neurosurgery Navigation and Therapy - Services

$503,0006%

Capital Equipment And Software

$396,0005%

Capital Equipment And Software - Services

$218,0002%

Capital Equipment And Software - Systems and Software Products

$178,0002%